NDC 0409-1810 - Novocaine

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 0409-1810
Package NDCs from labels: 0409-1810-02
Manufacturer: Hospira, Inc.
Effective date: 2007-08-28
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
NOVOCAIN ® PROCAINE HYDROCHLORIDE INJECTION, USP	Hospira, Inc.	2007-08-28	Human prescription drug label

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0409-1810-02	Novocaine	25 in 1 CARTON	INJECTION, SOLUTION	25	2
0409-1810-02	Novocaine	5 in 1 CONTAINER	INJECTION, SOLUTION	5	2
0409-1810-02	Novocaine	40 in 1 CASE	INJECTION, SOLUTION	40	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0409-1810	NOVOCAINE (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	2	3 package rows	20070914_999625D5-3A6B-4753-059A-4F19D04C85A5.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Procaine Hydrochloride	ACTIVE INGREDIENT	95URV01IDQ	NOVOCAINE (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	2
Procaine	ACTIVE MOIETY	4Z8Y51M438	NOVOCAINE (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	2
Acetone Sodium Bisulfite	INACTIVE INGREDIENT		NOVOCAINE (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	2

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 8 of 9 · 177 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cytarabine	CYTARABINE	Hospira, Inc.	e3a8c0e9-19ed-49b7-8464-11e8806f47fd	2025-04-07	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Docetaxel	DOCETAXEL	Hospira, Inc.	6b9999bb-869e-4d25-838c-23c3ab280044	2025-01-31	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Docetaxel	DOCETAXEL ANHYDROUS	Hospira, Inc.	644c5035-20d2-4686-beaa-bef08e99051c	2025-01-20	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Docetaxel	DOCETAXEL ANHYDROUS	Hospira, Inc.	00c61d11-d6b7-4618-b6f6-2592dbcc8af7	2025-01-20	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Vancomycin Hydrochloride	VANCOMYCIN HYDROCHLORIDE	Hospira, Inc.	91c050cf-3b2d-48bc-7297-e8dc68225e5a	2025-01-16	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
DOBUTAMINE	DOBUTAMINE	Hospira, Inc.	dc537761-d5f4-488d-24ab-b2bcd2b17b7a	2024-12-09	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Meropenem	MEROPENEM	Hospira, Inc.	e9b6555f-20a1-4415-bb80-3d034cfab95b	2024-11-06	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Meropenem	MEROPENEM	Hospira, Inc.	092ebd9b-77a0-4877-afc3-dd8211730f71	2024-11-06	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Ertapenem	ERTAPENEM	Hospira, Inc.	178a0356-4f6c-47fb-9913-f325a3c72f7b	2024-11-06	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Sodium Chloride	SODIUM CHLORIDE	Hospira, Inc.	8eb172da-dcd4-4660-4a8f-ad44a14b4af7	2024-11-06	Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Cefepime	CEFEPIME	Hospira, Inc.	e80c27e2-164d-4836-ba24-c160d75dc5d3	2024-11-06	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Docetaxel	DOCETAXEL	Hospira, Inc.	3104aab1-cd6e-4ad2-8e0a-286a0c5d1940	2024-09-19	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Docetaxel	DOCETAXEL ANHYDROUS	Hospira, Inc.	a0ec4bcc-93ea-4c41-a4b6-95ec19491807	2024-08-22	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Carboplatin	CARBOPLATIN	Hospira, Inc.	47677091-fd20-49af-933c-c9dd2be21de9	2024-08-21	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Gemcitabine	GEMCITABINE	Hospira, Inc.	d16907e7-a8c8-4039-ace4-cf4e24ba68c0	2024-08-16	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
GEMCITABINE	GEMCITABINE	Hospira, Inc.	a625c92b-c569-4b98-8d2e-2b3f5e12b34f	2024-08-16	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
PEMETREXED	PEMETREXED	Hospira, Inc.	3e087418-69ff-47fa-93c2-f28699309433	2024-07-24	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
TAZICEF	CEFTAZIDIME	Hospira, Inc.	1ab5ae3e-e303-4499-4c89-472d7cc1e46c	2024-07-04	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Carboplatin	CARBOPLATIN	Hospira, Inc.	c3ae9880-44bb-4f4e-93d8-8a5e21708a30	2024-06-20	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
LEVETIRACETAM	LEVETIRACETAM	Hospira, Inc.	f1935bc8-30ce-4b51-8a4c-0f12ce9000a6	2024-06-05	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.